Your browser doesn't support javascript.
loading
Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement.
Goldman, Jennifer L; Chung, Wen-Hung; Lee, Brian R; Chen, Chun-Bing; Lu, Chun-Wei; Hoetzenecker, Wolfram; Micheletti, Robert; Yasuda, Sally Usdin; Margolis, David J; Shear, Neil H; Struewing, Jeffery P; Pirmohamed, Munir.
Affiliation
  • Goldman JL; Department of Pediatrics, Divisions of Pediatric Infectious Diseases & Clinical Pharmacology, Children's Mercy Hospitals & Clinic, 2401 Gillham Rd., Kansas City, MO, 64108, USA. jlgoldman@cmh.edu.
  • Chung WH; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Keelung and Linkou Branches, College of Medicine, Chang Gung University, Taipei, Taiwan.
  • Lee BR; Division of Health Services and Outcomes Research, Children's Mercy Hospitals & Clinics, Kansas City, USA.
  • Chen CB; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Keelung and Linkou Branches, College of Medicine, Chang Gung University, Taipei, Taiwan.
  • Lu CW; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Keelung and Linkou Branches, College of Medicine, Chang Gung University, Taipei, Taiwan.
  • Hoetzenecker W; Department of Dermatology, University Hospital Linz, Linz, Austria.
  • Micheletti R; Department of Dermatology, University of Pennsylvania, Philadelphia, USA.
  • Yasuda SU; Food and Drug Administration, Silver Spring, USA.
  • Margolis DJ; Department of Dermatology, University of Pennsylvania, Philadelphia, USA.
  • Shear NH; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, USA.
  • Struewing JP; Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Center and University of Toronto, Toronto, Canada.
  • Pirmohamed M; Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA.
Eur J Clin Pharmacol ; 75(8): 1135-1141, 2019 Aug.
Article in En | MEDLINE | ID: mdl-30918988
ABSTRACT

PURPOSE:

Establishment of causality between drug exposure and adverse drug reactions (ADR) is challenging even for serious ADRs such as Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). Several causality assessment tools (CAT) exist, but the reliability and validity of such tools is variable. The objective of this study was to compare the reliability and validity of existing ADR CATs on SJS/TEN cases.

METHODS:

Seven investigators completed three CAT (ALDEN, Naranjo, Liverpool) for 10 SJS/TEN cases. Each CAT categorized the causality of 30 potential drugs as definite/very probable, probable, possible, or doubtful/unlikely. An additional reviewer provided expert opinion by designating the implicated drug(s) for each case. A Kappa score was generated to compare CAT responses both by method (reliability of all 7 reviewers, by CATs) and by reviewer (reliability of the 3 CAT, by reviewer). A c statistic was calculated to assess validity.

RESULTS:

Inter-rater reliability by CAT was poor to fair ALDEN 0.22, Naranjo 0.11, and Liverpool 0.12. Reliability was highest when causality classification was definite/very probable (0.16-0.41). Similarly, intra-rater reliability by reviewer was poor. When comparing the validity of the overall CAT to expert reviewer, area under the curve was highest for ALDEN (c statistic 0.65) as compared to Liverpool (0.55) or Naranjo (0.54).

CONCLUSION:

Available CAT have poor reliability and validity for drug-induced SJS/TEN. Due to the importance of determining ADR causality for research, industry, and regulatory purposes, development of an enhanced tool that can incorporate data from immunological testing and pharmacogenetic results may strengthen CAT usefulness and applicability for drug-induced SJS/TEN.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Causality / Stevens-Johnson Syndrome / Pharmacovigilance Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Clin Pharmacol Year: 2019 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Causality / Stevens-Johnson Syndrome / Pharmacovigilance Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Clin Pharmacol Year: 2019 Type: Article Affiliation country: United States